USPTO serial 79308808
NAVIN MOLECULAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 6, 2022
- Examiner
- SEVERSON, JUSTIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NAVIN MOLECULAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
NAVIN FLUORINE INTERNATIONAL LIMITED.
IN
Other trademarks owned by NAVIN FLUORINE INTERNATIONAL LIMITED.
NAVIN FLUORINE INTERNATIONAL LIMITED.
IN
Other trademarks owned by NAVIN FLUORINE INTERNATIONAL LIMITED.
NAVIN FLUORINE INTERNATIONAL LIMITED.
IN
Other trademarks owned by NAVIN FLUORINE INTERNATIONAL LIMITED.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexander Lazouski
Alexander Lazouski LAZOUSKI IP LLCSUITE 1, 14726 BOWFIN TER.LAKEWOOD RANCH, FL 34202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical preparations used in the manufacture of medicinal products, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for pharmaceuticals purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder chemical preparations for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for pharmaceuticals purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; medicinal and pharmaceutical preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for veterinary purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; disinfectants; insecticides; germicides; pesticides; preparations for fungicides, herbicides and preparations for destroying vermin | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NAVIN FLUORINE INTERNATIONAL LIMITED.
- Other trademarks owned by NAVIN FLUORINE INTERNATIONAL LIMITED.
- Other trademarks owned by NAVIN FLUORINE INTERNATIONAL LIMITED.
- Other trademarks in Class 005
- Similar marks named NAVIN MOLECULAR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 12, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 12, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 6, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 6, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 6, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 21, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 21, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 1, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 16, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 13, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 13, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 27, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 27, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 21, 2021 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 9, 2021 | ALIE | ASSIGNED TO LIE | — |
| Dec 8, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 6, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 6, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 6, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 19, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 1, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 1, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 22, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 21, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 20, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 16, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 15, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |